questionsmedicales.fr
Composés hétérocycliques
Composés hétérocycliques, cycle ponté
Tropanes
Dérivés de la scopolamine
Dérivés de la scopolamine : Questions médicales fréquentes
Diagnostic
5
Intoxication
Scopolamine
Symptômes
Évaluation neurologique
Fonction cognitive
Tests diagnostiques
Surdose
Hallucinations
Tachycardie
Effets secondaires
Interactions médicamenteuses
Dérivés
Signes cliniques
Mydriase
Sécheresse buccale
Symptômes
5
Nausées
Vomissements
Vertiges
Système nerveux
Neurotransmetteurs
Effets sédatifs
Effets secondaires
Somnolence
Sécheresse des muqueuses
Hallucinations
Surdosage
Effets psychologiques
Réaction allergique
Éruptions cutanées
Démangeaisons
Prévention
5
Prévention
Effets indésirables
Interactions médicamenteuses
Précautions
Maladies préexistantes
Grossesse
Enfants
Évaluation médicale
Sécurité
Conseils aux patients
Effets secondaires
Adhésion au traitement
Mal des transports
Patch de scopolamine
Efficacité
Traitements
5
Intoxication
Charbon actif
Soins de soutien
Antidotes
Physostigmine
Effets inversés
Mal des transports
Prévention
Scopolamine
Antihistaminiques
Médicaments antiémétiques
Effets secondaires
Administration
Voie transdermique
Voie orale
Complications
5
Complications
Troubles de la mémoire
Coordination
Problèmes cardiaques
Arythmies
Surdosage
Risques neurologiques
Convulsions
Troubles de la conscience
Gestion des complications
Surveillance médicale
Traitement symptomatique
Vision
Vision floue
Problèmes de focalisation
Facteurs de risque
5
Facteurs de risque
Âge avancé
Polypharmacie
Femmes enceintes
Éviter
Nécessité médicale
Médicaments
Antidépresseurs
Antihistaminiques
Personnes âgées
Sensibilité
Effets indésirables
Antécédents médicaux
Glaucome
Troubles cardiaques
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Dérivés de la scopolamine : Questions médicales les plus fréquentes",
"headline": "Dérivés de la scopolamine : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Dérivés de la scopolamine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-04",
"dateModified": "2025-03-31",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Dérivés de la scopolamine"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Tropanes",
"url": "https://questionsmedicales.fr/mesh/D014326",
"about": {
"@type": "MedicalCondition",
"name": "Tropanes",
"code": {
"@type": "MedicalCode",
"code": "D014326",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.605.869"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Bromure de N-butyl-scopolammonium",
"alternateName": "Butylscopolammonium Bromide",
"url": "https://questionsmedicales.fr/mesh/D002086",
"about": {
"@type": "MedicalCondition",
"name": "Bromure de N-butyl-scopolammonium",
"code": {
"@type": "MedicalCode",
"code": "D002086",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.605.869.822.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "N-Méthyl-scopolammonium",
"alternateName": "N-Methylscopolamine",
"url": "https://questionsmedicales.fr/mesh/D019832",
"about": {
"@type": "MedicalCondition",
"name": "N-Méthyl-scopolammonium",
"code": {
"@type": "MedicalCode",
"code": "D019832",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.605.869.822.550"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Scopolamine",
"alternateName": "Scopolamine",
"url": "https://questionsmedicales.fr/mesh/D012601",
"about": {
"@type": "MedicalCondition",
"name": "Scopolamine",
"code": {
"@type": "MedicalCode",
"code": "D012601",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.605.869.822.775"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Bromure de tiotropium",
"alternateName": "Tiotropium Bromide",
"url": "https://questionsmedicales.fr/mesh/D000069447",
"about": {
"@type": "MedicalCondition",
"name": "Bromure de tiotropium",
"code": {
"@type": "MedicalCode",
"code": "D000069447",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.605.869.822.887"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Dérivés de la scopolamine",
"alternateName": "Scopolamine Derivatives",
"code": {
"@type": "MedicalCode",
"code": "D012602",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Mahmoud Hosseini",
"url": "https://questionsmedicales.fr/author/Mahmoud%20Hosseini",
"affiliation": {
"@type": "Organization",
"name": "Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."
}
},
{
"@type": "Person",
"name": "Mohammad Shoaib",
"url": "https://questionsmedicales.fr/author/Mohammad%20Shoaib",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmacy, University of Malakand, Chakdara Dir Lower, KPK, Pakistan."
}
},
{
"@type": "Person",
"name": "Jong Hoon Ryu",
"url": "https://questionsmedicales.fr/author/Jong%20Hoon%20Ryu",
"affiliation": {
"@type": "Organization",
"name": "Department of Life and Nanopharmaceutical Science, Kyung Hee University, Seoul, 02447, Republic of Korea; Department of Oriental Pharmaceutical Science, Kyung Hee University, Seoul, 02447, Republic of Korea. Electronic address: jhryu63@khu.ac.kr."
}
},
{
"@type": "Person",
"name": "Farimah Beheshti",
"url": "https://questionsmedicales.fr/author/Farimah%20Beheshti",
"affiliation": {
"@type": "Organization",
"name": "Neuroscience Research Center, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran."
}
},
{
"@type": "Person",
"name": "Nasiara Karim",
"url": "https://questionsmedicales.fr/author/Nasiara%20Karim",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmacy, University of Peshawar, Peshawar, KPK, Pakistan."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Transdermal scopolamine and urinary retention following urogynecologic surgery: a systematic review and meta-analysis.",
"datePublished": "2023-01-31",
"url": "https://questionsmedicales.fr/article/36719449",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00192-023-05467-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Design and synthesis of 2-(2,2-diarylethyl)-cyclamine derivatives as M3 receptor antagonists and functional evaluation on COPD.",
"datePublished": "2022-11-30",
"url": "https://questionsmedicales.fr/article/36516520",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.bioorg.2022.106308"
}
},
{
"@type": "ScholarlyArticle",
"name": "Vanillin derivatives as antiamnesic agents in scopolamine-induced memory impairment in mice.",
"datePublished": "2024-02-19",
"url": "https://questionsmedicales.fr/article/38420420",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.heliyon.2024.e26657"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effect of budesonide formoterol combined with tiotropium bromide on pulmonary function and inflammatory factors in patients with asthma-COPD overlap syndrome.",
"datePublished": "2023-07-01",
"url": "https://questionsmedicales.fr/article/37422789",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.15586/aei.v51i4.876"
}
},
{
"@type": "ScholarlyArticle",
"name": "Immobilization of M3 Muscarinic Receptor to Rapidly Analyze Drug-Protein Interactions and Bioactive Components in a Natural Plant.",
"datePublished": "2023-04-12",
"url": "https://questionsmedicales.fr/article/37108332",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms24087171"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés hétérocycliques",
"item": "https://questionsmedicales.fr/mesh/D006571"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés hétérocycliques, cycle ponté",
"item": "https://questionsmedicales.fr/mesh/D006572"
},
{
"@type": "ListItem",
"position": 4,
"name": "Tropanes",
"item": "https://questionsmedicales.fr/mesh/D014326"
},
{
"@type": "ListItem",
"position": 5,
"name": "Dérivés de la scopolamine",
"item": "https://questionsmedicales.fr/mesh/D012602"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Dérivés de la scopolamine - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Dérivés de la scopolamine",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-02",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Dérivés de la scopolamine",
"description": "Comment diagnostiquer une intoxication à la scopolamine ?\nQuels tests sont utilisés pour évaluer l'effet des dérivés ?\nQuels symptômes indiquent une surdose de scopolamine ?\nComment différencier les effets des dérivés de la scopolamine ?\nQuels signes cliniques sont associés aux dérivés ?",
"url": "https://questionsmedicales.fr/mesh/D012602#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Dérivés de la scopolamine",
"description": "Quels sont les symptômes courants des dérivés de la scopolamine ?\nComment la scopolamine affecte-t-elle le système nerveux ?\nQuels effets secondaires sont associés à la scopolamine ?\nLa scopolamine peut-elle provoquer des hallucinations ?\nQuels symptômes indiquent une réaction allergique ?",
"url": "https://questionsmedicales.fr/mesh/D012602#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Dérivés de la scopolamine",
"description": "Comment prévenir les effets indésirables de la scopolamine ?\nQuelles précautions prendre avant d'utiliser la scopolamine ?\nLa scopolamine est-elle sûre pour les enfants ?\nQuels conseils donner aux patients utilisant la scopolamine ?\nComment éviter le mal des transports avec la scopolamine ?",
"url": "https://questionsmedicales.fr/mesh/D012602#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Dérivés de la scopolamine",
"description": "Comment traiter une intoxication à la scopolamine ?\nQuels médicaments sont utilisés pour contrer les effets de la scopolamine ?\nLa scopolamine est-elle utilisée pour traiter le mal des transports ?\nQuels traitements sont disponibles pour les effets secondaires ?\nComment la scopolamine est-elle administrée ?",
"url": "https://questionsmedicales.fr/mesh/D012602#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Dérivés de la scopolamine",
"description": "Quelles complications peuvent survenir avec la scopolamine ?\nLa scopolamine peut-elle provoquer des problèmes cardiaques ?\nQuels risques neurologiques sont associés à la scopolamine ?\nComment gérer les complications liées à la scopolamine ?\nLa scopolamine peut-elle affecter la vision ?",
"url": "https://questionsmedicales.fr/mesh/D012602#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Dérivés de la scopolamine",
"description": "Quels facteurs augmentent le risque d'effets secondaires ?\nLes femmes enceintes doivent-elles éviter la scopolamine ?\nQuels médicaments interagissent avec la scopolamine ?\nLes personnes âgées sont-elles plus sensibles à la scopolamine ?\nQuels antécédents médicaux augmentent les risques ?",
"url": "https://questionsmedicales.fr/mesh/D012602#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une intoxication à la scopolamine ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique médical et les symptômes cliniques observés."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'effet des dérivés ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de fonction cognitive et des évaluations neurologiques peuvent être réalisés."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une surdose de scopolamine ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent confusion, hallucinations, et tachycardie."
}
},
{
"@type": "Question",
"name": "Comment différencier les effets des dérivés de la scopolamine ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'analyse des effets secondaires et des interactions médicamenteuses aide à la différenciation."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques sont associés aux dérivés ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent sécheresse buccale, mydriase et troubles de la vision."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des dérivés de la scopolamine ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent nausées, vomissements, et vertiges."
}
},
{
"@type": "Question",
"name": "Comment la scopolamine affecte-t-elle le système nerveux ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle provoque une inhibition des neurotransmetteurs, entraînant des effets sédatifs."
}
},
{
"@type": "Question",
"name": "Quels effets secondaires sont associés à la scopolamine ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires incluent somnolence, confusion et sécheresse des muqueuses."
}
},
{
"@type": "Question",
"name": "La scopolamine peut-elle provoquer des hallucinations ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des hallucinations peuvent survenir, surtout en cas de surdosage."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une réaction allergique ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des éruptions cutanées, démangeaisons et gonflements peuvent indiquer une allergie."
}
},
{
"@type": "Question",
"name": "Comment prévenir les effets indésirables de la scopolamine ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est essentiel de suivre les doses prescrites et d'éviter les interactions médicamenteuses."
}
},
{
"@type": "Question",
"name": "Quelles précautions prendre avant d'utiliser la scopolamine ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consulter un médecin, surtout en cas de maladies préexistantes ou de grossesse."
}
},
{
"@type": "Question",
"name": "La scopolamine est-elle sûre pour les enfants ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Son utilisation chez les enfants doit être soigneusement évaluée par un médecin."
}
},
{
"@type": "Question",
"name": "Quels conseils donner aux patients utilisant la scopolamine ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Informer sur les effets secondaires possibles et l'importance de l'adhésion au traitement."
}
},
{
"@type": "Question",
"name": "Comment éviter le mal des transports avec la scopolamine ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser le patch de scopolamine quelques heures avant le voyage pour une efficacité optimale."
}
},
{
"@type": "Question",
"name": "Comment traiter une intoxication à la scopolamine ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement inclut l'administration de charbon actif et des soins de soutien."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont utilisés pour contrer les effets de la scopolamine ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antidotes comme la physostigmine peuvent être administrés pour inverser les effets."
}
},
{
"@type": "Question",
"name": "La scopolamine est-elle utilisée pour traiter le mal des transports ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle est souvent prescrite pour prévenir le mal des transports."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les effets secondaires ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antihistaminiques et des médicaments antiémétiques peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Comment la scopolamine est-elle administrée ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut être administrée par voie transdermique, orale ou injectable."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec la scopolamine ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des troubles de la mémoire et des problèmes de coordination."
}
},
{
"@type": "Question",
"name": "La scopolamine peut-elle provoquer des problèmes cardiaques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner des arythmies cardiaques, surtout en cas de surdosage."
}
},
{
"@type": "Question",
"name": "Quels risques neurologiques sont associés à la scopolamine ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des risques incluent des convulsions et des troubles de la conscience."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications liées à la scopolamine ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surveillance médicale étroite et un traitement symptomatique sont nécessaires."
}
},
{
"@type": "Question",
"name": "La scopolamine peut-elle affecter la vision ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut provoquer une vision floue et des problèmes de focalisation."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'effets secondaires ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge avancé, les maladies chroniques et la polypharmacie augmentent les risques."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes doivent-elles éviter la scopolamine ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, son utilisation doit être évitée sauf en cas de nécessité médicale avérée."
}
},
{
"@type": "Question",
"name": "Quels médicaments interagissent avec la scopolamine ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antidépresseurs et les antihistaminiques peuvent interagir avec la scopolamine."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus sensibles à la scopolamine ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont plus susceptibles de développer des effets indésirables."
}
},
{
"@type": "Question",
"name": "Quels antécédents médicaux augmentent les risques ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents de glaucome ou de troubles cardiaques augmentent les risques."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 31/03/2025
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Publications dans "Dérivés de la scopolamine" :
3 publications dans cette catégorie
Affiliations :
Department of Pharmacy, University of Malakand, Chakdara Dir Lower, KPK, Pakistan.
Publications dans "Dérivés de la scopolamine" :
3 publications dans cette catégorie
Affiliations :
Department of Life and Nanopharmaceutical Science, Kyung Hee University, Seoul, 02447, Republic of Korea; Department of Oriental Pharmaceutical Science, Kyung Hee University, Seoul, 02447, Republic of Korea. Electronic address: jhryu63@khu.ac.kr.
Publications dans "Dérivés de la scopolamine" :
3 publications dans cette catégorie
Affiliations :
Neuroscience Research Center, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran.
Department of Physiology, School of Paramedical Sciences, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran.
Publications dans "Dérivés de la scopolamine" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacy, University of Peshawar, Peshawar, KPK, Pakistan.
Publications dans "Dérivés de la scopolamine" :
2 publications dans cette catégorie
Affiliations :
Department of Biochemistry, University of Malakand Chakdara Dir Lower, KPK, Pakistan.
Publications dans "Dérivés de la scopolamine" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacy, University of Malakand, Dir (Lower), Chakdara 18800, Khyber Pakhtunkhwa, Pakistan.
Publications dans "Dérivés de la scopolamine" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacy, University of Malakand, Dir (Lower), Chakdara 18800, Khyber Pakhtunkhwa, Pakistan.
Publications dans "Dérivés de la scopolamine" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacy, Banasthali Vidyapith, Banasthali, Rajasthan, India.
Publications dans "Dérivés de la scopolamine" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacy, Banasthali Vidyapith, Banasthali, Rajasthan, India.
Publications dans "Dérivés de la scopolamine" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacy, Banasthali Vidyapith, Banasthali, Rajasthan, India.
Publications dans "Dérivés de la scopolamine" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacy, Banasthali Vidyapith, Banasthali, Rajasthan, India.
Publications dans "Dérivés de la scopolamine" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacy, Banasthali Vidyapith, Banasthali, Rajasthan, India. Electronic address: nainsumitra@gmail.com.
Publications dans "Dérivés de la scopolamine" :
2 publications dans cette catégorie
Affiliations :
National Engineering Research Center of Seafood, School of Food Science and Technology, Dalian Polytechnic University, Dalian 116034, P. R. China.
Publications dans "Dérivés de la scopolamine" :
2 publications dans cette catégorie
Affiliations :
Department of Life and Nanopharmaceutical Science, Kyung Hee University, Seoul, 02447, Republic of Korea.
Publications dans "Dérivés de la scopolamine" :
2 publications dans cette catégorie
Affiliations :
Department of Life and Nanopharmaceutical Science, Kyung Hee University, Seoul, 02447, Republic of Korea.
Publications dans "Dérivés de la scopolamine" :
2 publications dans cette catégorie
Affiliations :
Department of Life and Nanopharmaceutical Science, Kyung Hee University, Seoul, 02447, Republic of Korea.
Publications dans "Dérivés de la scopolamine" :
2 publications dans cette catégorie
Affiliations :
Department of Biology, Faculty of Biology, Alexandru Ioan Cuza University of Iasi, Bd. Carol I, No. 11, 700505 Iasi, Romania.
Publications dans "Dérivés de la scopolamine" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacognosy, Faculty of Pharmacy, Ain Shams University, Abbassia, Cairo 11566, Egypt.
Center of Drug Discovery Research and Development, Ain Shams University, Abbassia, Cairo 11566, Egypt.
Publications dans "Dérivés de la scopolamine" :
2 publications dans cette catégorie
Affiliations :
Department of Biology, Faculty of Biology, Alexandru Ioan Cuza University of Iasi, Bd. Carol I, No. 11, 700505 Iasi, Romania.
Publications dans "Dérivés de la scopolamine" :
Both urogynecologic surgeries and transdermal scopolamine (TDS) patches are independently associated with postoperative urinary retention (POUR). It is unclear if the risk of POUR increases when these...
This systematic review was conducted in concordance with the PRISMA 2020 guidelines. MEDLINE, ClinicalTrials.gov, and Cochrane Library were searched. Publications were filtered by inclusion and exclus...
Four publications were identified which complied with inclusion and exclusion criteria. Included studies comprised 752 patients (237 experimental group, 515 control group). All were retrospective coho...
Current evidence suggests that TDS application may be associated with increased risk of POUR following urogynecologic procedures. While research on this topic is greatly limited, this systematic revie...
Muscarine acetylcholine receptors (mAChRs) regulate a variety of central and peripheral physiological functions and emerge as important therapeutic targets for a number of diseases including chronic o...
Amnesia is a major health problem prevalent in almost every part of the world specifically in old age peoples. Vanillin analogues have played an important role in the field medicines. Some of them hav...
To investigate the clinical efficacy of combining budesonide formoterol with tiotropium bromide for treating asthma-chronic obstructive pulmonary disease overlap syndrome (AOCS)....
The data of 104 patients with AOCS admitted to our hospital from December 2019 to December 2020 were assessed, randomly and divided into an experimental group (comprising 52 patients, receiving drug c...
Prior to treatment, no significant differences were observed in various pulmonary function indicators, FeNO, immune function, endothelial function, and lipid peroxidation injury indexes between the tw...
The combination of budesonide formoterol to tiotropium bromide in treating asthma-COPD overlap syndrome may significantly improve pulmonary function, endothelial function, and immune status of patient...
Despite its increasing application in pursing potential ligands, the capacity of receptor affinity chromatography is greatly challenged as most current research studies lack a comprehensive characteri...
Motion sickness is a syndrome that occurs as a result of passive body movement in response to actual motion, or the illusion of motion when exposed to virtual and moving visual environments. The most ...
To assess the effectiveness of antihistamines in the prevention and treatment of motion sickness in adults and children....
The Cochrane ENT Information Specialist searched the Cochrane ENT Register; Central Register of Controlled Trials; Ovid MEDLINE; Ovid Embase; Web of Science; ClinicalTrials.gov; ICTRP and additional s...
Randomised controlled trials (RCTs) in susceptible adults and children in whom motion sickness was induced under natural conditions such as air, sea and land transportation. We also included studies i...
We used standard Cochrane methods. Our primary outcomes were 1) the proportion of susceptible participants who did not experience any motion sickness symptoms; 2) the proportion of susceptible partici...
We included nine RCTs (658 participants). Studies were conducted across seven countries, with an overall age range of 16 to 55 years. Motion sickness was induced naturally in six studies and experimen...
There is probably a reduction in the risk of developing motion sickness symptoms under naturally occurring conditions of motion when using first-generation antihistamines, in motion sickness-susceptib...
Major Depressive Disorder (MDD) is a very complex disease, challenging to study and manage. The complexities of MDD require extensive research of its mechanisms to develop more effective therapeutic a...
This manuscript aims to explore the complex relationship between MDD and BDNF signaling pathway, focusing on how BDNF is modulated in response to oxidative stress and corticosterone, known to be alter...
To assess BDNF levels after the different treatment conditions, rat hippocampal slices and mice primary hippocampus and cortical cell culture were analyzed by immunofluorescence and Western blot....
Both mirtazapine and scopolamine under stress conditions induced by hydrogen peroxide (H...
Collectively, this study highlights the complex connection between these compounds, stress conditions, and BDNF/TrkB modulation, supporting the potential therapeutic effects of scopolamine and mirtaza...
There are limited studies on the use of bronchodilators for the treatment of bronchiectasis. This study investigated the efficacy of tiotropium in patients with bronchiectasis and airflow limitation....
This study was a prospective cohort study, including 169 patients with bronchiectasis and airflow limitation from 2015 to 2019. The clinical outcomes observed in our study were the effect of tiotropiu...
After 12 months, the annual decline in the FEV...
In conclusion, prospective cohort study showed that tiotropium effectively ameliorated the annual decline in the FEV...
For decades, treatment of mood disorders, psychoses, anxiety and dementia have been confounded by limited efficacy and high rates of treatment resistance. Preclinical and clinical evidence have highli...
PubMed, EMBASE, PsycINFO, EBSCO and Web of Science were searched using relevant keywords from database inception to 7 August 2022. Randomised, double-blind, placebo-controlled studies were included if...
Overall, 33 studies met the inclusion criteria and 5 were included in the meta-analysis. Despite a limited pool with several different interventions, we found therapeutic efficacy of xanomeline (M...
While the results are not definitive, findings on muscarinic receptor-targeted interventions in several mental disorders are promising in terms of efficacy and safety, specifically in treating schizop...
Tiotropium...
In a randomised, double-blind, two-period crossover trial, we recruited adult patients from three hospitals in New Zealand. Patients were excluded if they had a smoking history of >20 pack-years. Pati...
90 patients were randomly assigned and 85 completed both treatment cycles. The rate of exacerbations was 2.17 per year under the tiotropium treatment and 2.27 per year under placebo (rate ratio 0.96, ...
Tiotropium...